Cargando…

ACPA fine-specificity profiles in early rheumatoid arthritis patients do not correlate with clinical features at baseline or with disease progression

INTRODUCTION: Autoantibodies against citrullinated peptides/proteins (ACPA) are found in approximately 75% of the sera of patients with rheumatoid arthritis (RA). The RA-specific ACPA are frequently present prior to disease onset and their presence associates with a more erosive disease course. ACPA...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Beers, Joyce JBC, Willemze, Annemiek, Jansen, Jeroen J, Engbers, Gerard HM, Salden, Martin, Raats, Jos, Drijfhout, Jan W, van der Helm-van Mil, Annette HM, Toes, Rene EM, Pruijn, Ger JM
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978944/ https://www.ncbi.nlm.nih.gov/pubmed/24286543 http://dx.doi.org/10.1186/ar4322

Ejemplares similares

Anti-citrullinated fibronectin antibodies in rheumatoid arthritis are associated with human leukocyte antigen-DRB1 shared epitope alleles
por: van Beers, Joyce JBC, et al.
Publicado: (2012)

The fine specificity of IgM anti-citrullinated protein antibodies (ACPA) is different from that of IgG ACPA
por: Suwannalai, Parawee, et al.
Publicado: (2011)

MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF
por: Boeters, Debbie M., et al.
Publicado: (2016)

Inflammation functions as a key mediator in the link between ACPA and erosion development: an association study in Clinically Suspect Arthralgia
por: ten Brinck, R. M., et al.
Publicado: (2018)

The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical
por: Boeters, Debbie M., et al.
Publicado: (2017)

Sequential Prodrug Strategy To Target and Eliminate ACPA-Selective Autoreactive B Cells
por: Lelieveldt, Lianne P. W. M., et al.
Publicado: (2018)

Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?
por: De Rooy, Diederik PC, et al.
Publicado: (2011)

An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting
por: van Heemst, Jurgen, et al.
Publicado: (2015)

ACPA-negative and ACPA-positive RA patients achieving disease resolution demonstrate distinct patterns of MRI-detected joint-inflammation
por: Verstappen, Marloes, et al.
Publicado: (2022)

Immunoprofiling of early, untreated rheumatoid arthritis using mass cytometry reveals an activated basophil subset inversely linked to ACPA status
por: Koppejan, H., et al.
Publicado: (2021)

Elevated levels of fibrinogen-derived endogenous citrullinated peptides in synovial fluid of rheumatoid arthritis patients
por: Raijmakers, Reinout, et al.
Publicado: (2012)

Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis
por: van der Helm-van Mil, Annette HM, et al.
Publicado: (2005)

Fine-specificity of the antibodies against citrullinated protein response is influenced by shared epitope alleles
por: Verpoort, KN, et al.
Publicado: (2007)

The prognostic value of baseline erosions in undifferentiated arthritis
por: Thabet, Mohamed M, et al.
Publicado: (2009)

Response to: “Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation” by Masi and Fleischmann
por: Boeters, Debbie M., et al.
Publicado: (2020)

Mapping of citrullinated fibrinogen B-cell epitopes in rheumatoid arthritis by imaging surface plasmon resonance
por: van Beers, Joyce JBC, et al.
Publicado: (2010)

Correction to: Response to: “Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation” by Masi and Fleischmann
por: Boeters, Debbie M., et al.
Publicado: (2020)

Differing time-orders of inflammation decrease between ACPA subsets in RA patients suggest differences in underlying inflammatory pathways
por: Matthijssen, Xanthe M E, et al.
Publicado: (2020)

Therapeutic ACPA inhibits NET formation: a potential therapy for neutrophil-mediated inflammatory diseases
por: Chirivi, Renato G. S., et al.
Publicado: (2020)

MPP6 is an exosome-associated RNA-binding protein involved in 5.8S rRNA maturation
por: Schilders, Geurt, et al.
Publicado: (2005)

Unraveling heterogeneity within ACPA-negative rheumatoid arthritis: the subgroup of patients with a strong clinical and serological response to initiation of DMARD treatment favor disease resolution
por: Verstappen, M., et al.
Publicado: (2022)

Autoantibodies specific for apoptotic U1-70K are superior serological markers for mixed connective tissue disease
por: Hof, Daniëlle, et al.
Publicado: (2005)

Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets
por: van der Helm-van Mil, Annette HM, et al.
Publicado: (2008)

ACPA-negative RA consists of subgroups: patients with high likelihood of achieving sustained DMARD-free remission can be identified by serological markers at disease presentation
por: Boeters, Debbie M., et al.
Publicado: (2019)

TRAF1/C5 polymorphism is not associated with increased mortality in rheumatoid arthritis: two large longitudinal studies
por: van Nies, Jessica AB, et al.
Publicado: (2010)

A prospective cohort study of 14-3-3η in ACPA and/or RF-positive patients with arthralgia
por: van Beers-Tas, Marian H., et al.
Publicado: (2016)

An important step towards completing the rheumatoid arthritis cycle
por: van Venrooij, Walther J, et al.
Publicado: (2008)

How citrullination invaded rheumatoid arthritis research
por: van Venrooij, Walther J, et al.
Publicado: (2014)

CCR6(+) Th cell populations distinguish ACPA positive from ACPA negative rheumatoid arthritis
por: Paulissen, Sandra M. J., et al.
Publicado: (2015)

Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association
por: van den Beukel, Michelle D, et al.
Publicado: (2023)

Aspects of early arthritis. Definition of disease states in early arthritis: remission versus minimal disease activity
por: van der Helm-van Mil, Annette HM, et al.
Publicado: (2006)

Response to the ACPA's critique.
por: Repetto, R, et al.
Publicado: (1998)

The RNA interference pathway: a new target for autoimmunity
por: Pruijn, Ger JM
Publicado: (2006)

To treat or not to treat? Current attitudes on treatment aimed at modifying the disease burden in clinically suspect arthralgia: a survey among participants of the TREAT EARLIER trial and healthcare professionals
por: Krijbolder, Doortje I, et al.
Publicado: (2023)

C1D and hMtr4p associate with the human exosome subunit PM/Scl-100 and are involved in pre-rRNA processing
por: Schilders, Geurt, et al.
Publicado: (2007)

The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis
por: Pruijn, Ger JM, et al.
Publicado: (2010)

The human exosome: an autoantigenic complex of exoribonucleases in myositis and scleroderma
por: Brouwer, Rick, et al.
Publicado: (2001)

Autoantikörper und die autoreaktive Immunantwort: ACPA sind mehr als nur ACPA
por: Scherer, H. U.
Publicado: (2020)

The value of MRI for detecting subclinical joint inflammation in clinically suspect arthralgia
por: Boeren, Anna M. P., et al.
Publicado: (2022)

The value of inquiring about functional impairments for early identification of inflammatory arthritis: a large cross-sectional derivation and validation study from the Netherlands
por: van Dijk, Bastiaan T, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ov9mup2m196v7kk5p5a1vm1c5g